Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient β2-microglobulin-null mice

Experimental Biology and Medicine

Volumn 228, Issue 9, 2003, Pages 1096-1104

  Turgeon, Nicole A ^a   Banuelos, Scott J ^a   Shultz, Leonard D ^b   Lyons, Bonnie L ^b   Iwakoshi, Neal ^a   Greiner, Dale L ^a   Mordes, John P ^a   Rossini, Aldo A ^a   Appel, Michael C ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Graft rejection; hu PBL scid; Skin allograft; Transplantation

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IN VIVO STUDY; LYMPHOCYTE; MALE; MONONUCLEAR PHAGOCYTE; MOUSE; MOUSE STRAIN; NON OBESE DIABETIC SEVERE COMBINED IMMUNODEFICIENT BETA 2 MICROGLOBULIN NULL MOUSE; NONHUMAN; NULL ALLELE; OBESITY; SCID MOUSE; SENSITIZATION; SKIN GRAFT; T LYMPHOCYTE SUBPOPULATION;

ANIMALIA;

EID: 0141640842     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322800918     Document Type: Article

References (38)

1. Auchincloss H Jr, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 16:433-470, 1998.
2. Gudmundsdottir H, Turka LA. Transplantation tolerance: Mechanisms and strategies? Semin Nephrol 20:209-216, 2000.
3. Waldmann H. Transplantation tolerance: Where do we stand? Nat Med 5:1245-1248, 1999.
4. Adler SH, Bensinger SJ, Turka LA. Stemming the tide of rejection. Nat Med 8:107-108, 2002.
5. Carpenter C. Improving the success of organ transplantation (editorial). N Engl J Med 342:647-648, 2000.
6. Marmont AM. New horizons in the treatment of autoimmune diseases: Immunoablation and stem cell transplantation. Annu Rev Med 51:115-134, 2000.
7. Rossini AA, Greiner DL, Mordes JP. Induction of immunological tolerance for transplantation. Physiol Rev 79:99-141, 1999.
8. Gourishankar S, Turner P, Halloran P. New developments in immunosuppressive therapy in renal transplantation. Expert Opin Biol Ther 2:483-501, 2002.
9. Greiner D, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells 16:166-177, 1998.
10. Greiner DL, Shultz LD. Use of NOD/LtSz-scid/scid mice in biomedical research. In: Leiter EH, Atkinson MA, Eds. NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and Other Diseases. Austin, TX: R.G. Landes Co., pp173-203, 1998.
11. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639, 1988.
12. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259, 1988.
13. Cao T, Leroux-Roels G. Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain. Clin Exp Immunol 122:117-123, 2000.
14. Murphy WJ, Funakoshi S, Fanslow WC, Rager HC, Taub DD, Longo DL. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras. Clin Immunol 90:22-27, 1999.
15. Nguyen H, Hay J, Mazzulli T, Gallinger S, Sandhu J, Teng Y, Hozumi N. Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries. Clin Exp Immunol 122:85-93, 2000.
16. 2-microglobulin-deficient NOD-scid mice. J Immunol 158:3578-3586, 1997.
17. Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in HuPBL-scid mice. J Immunol 165:518-527, 2000.
18. Tanaka T, Tsudo M, Karasuyama H, Kitamura F, Kono T, Hatakeyama M, Taniguchi T, Miyasaka M. A novel monoclonal antibody against murine IL-2 receptor beta-chain: Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol 147:2222-2228. 1991.
19. Turgeon N, Iwakoshi NN, Meyers W, Shultz L, Greiner DL, Mordes JP, Rossini AA. Analysis of human immune responses to human allografts in small animal models. Surg Forum 50:393-395, 1999.
20. Murray AG, Schechner JS, Epperson DE, Sultan P, McNiff JM, Hughes CC, Lorber MI, Askenase PW, Pober JS. Dermal microvascular injury in the human peripheral blood lymphocyte reconstitutedsevere combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin. Am J Pathol 153:627-638, 1998.
21. Tournoy KG, Depraetere S, Pauwels RA, Leroux-Roels GG. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice. Clin Exp Immunol 119:231-239, 2000.
22. Foy TM, Mcllraith M, Masters SR, Dunn JJ, Rossini AA, Shultz LD. Hesselton RA, Wagar EJ, Lipsky PE, Noelle RJ, Greiner DL. Blockade of CD40-CD154 interferes with human T cell engraftment in scid mice. Cell Transplantation 7:25-35, 1998.
23. Murray AG, Petzelbauer P, Hughes CC, Costa J, Askenase P, Pober JS. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci USA 91:9146-9150, 1994.
24. Sultan P, Schechner JS, McNiff JM, Hochman PS, Hughes CC, Lorber MI, Askenase PW, Pober JS. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nat Biotechnol 15:759-762, 1997.
25. Kawamura T, Niguma T, Fechner JH Jr., Wolber R, Beeskau MA, Hullett DA, Sollinger HW, Burlingham WJ. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor. Transplantation 53:659-665, 1992.
26. Huppes W, Hoffmann-Fezer G. Peripheral blood leukocyte grafts that induce human to mouse graft-vs.-host disease reject allogeneic human skin grafts. Am J Pathol 147:1708-1714, 1995.
27. Alegre ML, Peterson LJ, Jeyarajah DR, Weiser M, Bluestone JA, Thistlethwaite JR. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol 153:2738-2749, 1994.
28. + T cells mediate rejection of porcine xenografts. J Immunol 162:5256-5262, 1999.
29. + T-cells in rejection of porcine islet cell xenografts. Diabetes 48:2340-2348, 1999.
30. Platt JL. New directions for organ transplantation. Nature 392:11-17, 1998.
31. Sawada T, DellaPelle PA,. Seebach JD, Sachs DH, Colvin RB, Iacomini J. Human cell-mediated rejection of porcine xenografts in an immunodeficient mouse model. Transplantation 63:1331-1338, 1997.
32. Shiroki R, Nazirrudin B, Hoshinaga K, Naide Y, Scharp DW, Mohanakumar T. Human peripheral blood lymphocyte-reconstituted, severe combined immunodeficient mice as a model for porcine islet xenograft rejection in humans. Artif Organs 20:878-882, 1996.
33. Zeng Y, Peterson L, Levisetti M, Torres M, Montag A, Thistlethwaite JR, Jr. Immunomodulation of human islets results in prolonged in vivo islet graft survival. Transplant Proc 27:611-612, 1995.
34. Dvorak HF, Mihm MC Jr., Dvorak AM, Barnes BA, Manseau EJ, Galli SJ. Rejection of first-set skin allografts in man. The microvasculature is the critical target of the immune response. J Exp Med 150:322-337, 1979.
35. Lorber MI, Wilson JH, Robert ME, Schechner JS, Kirkiles N, Qiar HY, Askenase PW, Tellides G, Pober JS. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantatior 67:897-903, 1999.
36. + T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 164:512-521, 2000.
37. + cells are essential for allorejection. J Exp Med 184:2013-2018, 1996.
38. Grusby MJ, Auchincloss H Jr., Lee R, Johnson RS, Spencer JP, Zijlstra M. Jaenisch R, Papaioannou VE, Glimcher LH. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 90:3913-3917, 1993.